TELL Toolkit
Buenos Aires
About TELL Toolkit
TELL is on a mission to revolutionize the fight against neurodegenerative diseases like Alzheimer's, Parkinson's, and frontotemporal dementia. The company's innovative approach to brain health combines automated speech and language analysis with cutting-edge AI technology to detect early markers and provide reliable data to get to diagnoses. The company's HIPAA-compliant SaaS solution is designed to address the challenges of early detection, specificity, cost, access, and reliability. By offering a unified, user-friendly, and scalable tool for discovering and implementing novel markers, we're bringing hope to patients, caregivers, and healthcare professionals across the globe. So, whether you're a patient, physician, biotech company, health insurance provider, or government agency, TELL is here to help you make better decisions and improve brain health for all.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $500.0K
- Funding stage: Seed
- Last round: Grant (Feb 2025)
- Website: tellapp.org
- Phone: +59891793559
Industries & Categories
Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/tell-toolkit-150592 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.